H2 Leaving Page Headline
Ut eum dolor sanis et at voluptur sintin corro of- fi cimpere nonsequis uta elia nimpo Datenschutzhinweise riorem aquam.
Do you want to link to another Amgen Canada site?
You are now leaving the Aranesp.ca website. Please note that these links are being provided as a convenience and for informational purposes only.
You are now leaving the Aranesp.ca website
The linked sites are not under the control of Amgen, and Amgen is not responsible for the content available on the linked sites. Such links do not imply Amgen's endorsement of material on any other site, and Amgen disclaims all liability with regard to your access to such linked websites. Amgen provides links to other Internet sites as a convenience to users, and access to such linked sites is at your own risk.
How do I take Aranesp®?
Aranesp® is given to patients as an injection. For patients with chronic kidney disease, one of the following methods will be used:
- Under your skin (subcutaneous); or
- Into the venous line connecting the hemodialysis machine to your vein (intravenous), if you are on hemodialysis.
You and your doctor will determine which is best for you. Your doctor will determine how much you must take and how often you need to take it. Aranesp® is given once a week or in some cases, once every two weeks.
You should ask your doctor what to do if you miss a dose of Aranesp®.